Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori

Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori

Aim. To evaluate the eradication rate, safety, and compliance of minocycline-containing bismuth quadruple regimens in patients with an untreated Helicobacter pylori (H. pylori) infection. Methods. A total of 360 patients with an untreated H. pylori infection were enrolled in this study between June...

Full description

Bibliographic Details
Main Authors:	Lingyun Zhang, Yu Lan, Qi Wang, Yuexia Zhang, Xiaobei Si
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2019/9251879

Similar Items

Corrigendum to “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori”
by: Lingyun Zhang, et al.
Published: (2021-01-01)

Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for Helicobacter pylori infection
by: Chang Seok Bang, et al.
Published: (2020-09-01)

Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
by: Mohammadreza Seyyedmajidi, et al.
Published: (2019-03-01)

Comparison of the impact of Helicobacter pylori eradication treatment with bismuth and non-bismuth quadruple regimens on the gut microbiota
by: S. Prast-Nielsen, et al.
Published: (2019-11-01)

The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication
by: Abbas Arj, et al.
Published: (2020-01-01)

Efficacy of a bismuth-based quadruple therapy regimen for Helicobacter pylori eradication in Saudi Arabia
by: Fahad Alsohaibani, et al.
Published: (2020-01-01)

Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection
by: Guang-Hong Jheng, et al.
Published: (2015-01-01)

Inefficacy of triple therapy and comparison of two different bismuth-containing quadruple regimens as a firstline treatment option for helicobacter pylori
by: Murat Kekilli, et al.
Published: (2016-01-01)

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
by: Gisbert JP, et al.
Published: (2012-03-01)

Bismuth-Based Quadruple Therapy with Bismuth Subcitrate, Metronidazole, Tetracycline and Omeprazole in the Eradication of Helicobacter pylori
by: Raymond Lahaie, et al.
Published: (2001-01-01)

The Efficacy of Bismuth-containing Quadruple Therapy after Moxifloxacin-based Sequential Therapy Failure in Helicobacter pylori Eradication
by: Soohoon Kwon, et al.
Published: (2018-04-01)

A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis
by: Sung Eun Kim, et al.
Published: (2021-03-01)

Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
by: Huang HT, et al.
Published: (2018-10-01)

Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
by: Hassan Salmanroghani, et al.
Published: (2018-01-01)

Rescue effects of Lactobacillus-containing bismuth regimens after Helicobacter pylori treatment failure
by: M. Karbalaei, et al.
Published: (2021-07-01)

Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy
by: F. Zhang, et al.
Published: (2016-01-01)

Clarithromycin versus Gemifloxacin in Quadruple Therapeutic Regimens for Helicobacter Pylori Infection Eradication
by: Fariborz Mansour-Ghanaei, et al.
Published: (2017-04-01)

Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori
by: Tariq H, et al.
Published: (2020-01-01)

Second-Line Bismuth-Containing Quadruple Therapy for <i>Helicobacter</i><i>pylori</i> Infection: A 12-Year Study of Annual Eradication Rates
by: Kiwon Shin, et al.
Published: (2021-07-01)

Effectiveness of Second through Sixth Line Salvage Helicobacter pylori Treatment: Bismuth Quadruple Therapy is Almost Always a Reasonable Choice
by: Tahir Shaikh, et al.
Published: (2016-01-01)

A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naïve and previously treated patients
by: Blas José Gómez-Rodríguez, et al.

Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line Helicobacter pylori Eradication Therapy
by: Sung Eun Kim, et al.
Published: (2019-01-01)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
by: Hung KT, et al.
Published: (2021-03-01)

Treatment with compound Lactobacillus acidophilus followed by a tetracycline- and furazolidone-containing quadruple regimen as a rescue therapy for Helicobacter pylori infection
by: Airu Liu, et al.
Published: (2020-01-01)

The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen
by: Joonhwan Kim, et al.
Published: (2018-04-01)

Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for <i>Helicobacter pylori</i> eradication in dyspepsia
by: Agah Shahram, et al.
Published: (2009-01-01)

Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication
by: Wei-Chen Tai, et al.
Published: (2015-01-01)

Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial
by: Young-Il Kim, et al.
Published: (2021-03-01)

Helicobacter Pylori Eradication in Renal Recipient: Triple or Quadruple Therapy?
by: Seyed Mousal Reza Hosseini, et al.
Published: (2014-04-01)

Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin
by: Zhiqiang Song, et al.
Published: (2019-07-01)

Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter pylori
by: Meng-Chieh Wu, et al.
Published: (2017-01-01)

Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian Perspective
by: Muhammad Miftahussurur, et al.
Published: (2015-04-01)

High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea
by: WonGun Kwack, et al.
Published: (2016-01-01)

The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease
by: A M Veliev, et al.
Published: (2019-08-01)

Two-day, high dosage, quadruple therapy for eradication of Helicobacter pylori
by: Zheng, Zhi-Xian, et al.

Impact of previous metronidazole exposure on metronidazole-based second-line quadruple therapy for Helicobacter pylori infection
by: Gil Ho Lee, et al.
Published: (2020-09-01)

Colloidal Bismuth Subcitrate in the Treatment of Helicobacter Pylori Infection
by: A.E. Dorofeiev, et al.
Published: (2016-02-01)

Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study
by: Antonietta G. Gravina, et al.
Published: (2021-04-01)

Effect of bismuth addition to the triple therapy of Helicobacter pylori eradication
by: Ezel Taşdemir, et al.
Published: (2012-03-01)

Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial
by: Marouf Alhalabi, et al.
Published: (2021-07-01)